Haematological disorders following kidney transplantation.

Jolanta Malyszko, Grzegorz Basak, Krzysztof Batko, Giavambatista Capasso, Anna Capasso, Joanna Drozd-Sokolowska, Katarzyna Krzanowska, Pawel Kulicki, Joanna Matuszkiewicz-Rowinska, Maria Jose Soler, Ben Sprangers, Jacek Malyszko

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2022;37(3):409-420

PMID: 33150431

Abstract

Transplantation offers cure for some haematological cancers, end-stage organ failure, but at the cost of long-term complications. Renal transplantation is the best-known kidney replacement therapy and it can prolong end-stage renal disease patient lives for decades. However, patients after renal transplantation are at a higher risk of developing different complications connected not only with surgical procedure but also with immunosuppressive treatment, chronic kidney disease progression and rejection processes. Various blood disorders can develop in post-transplant patients ranging from relatively benign anaemia through cytopenias to therapy-related myelodysplasia and acute myeloid leukaemia (AML) and post-transplant lymphoproliferative disorders followed by a rare and fatal condition of thrombotic microangiopathy and haemophagocytic syndrome. So far literature mainly focused on the post-transplant lymphoproliferative disease. In this review, a variety of haematological problems after transplantation ranging from rare disorders such as myelodysplasia and AML to relatively common conditions such as anaemia and iron deficiency are presented with up-to-date diagnosis and management.

© The Author(s) 2020. Published by Oxford University Press on behalf of the ERA.

Address: Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.; Department of Nephrology, Collegium Medicum, Jagiellonian University, Cracow, Poland.; Department of Translational Medical Sciences, University Luigi Vanvitelli, Naples, Italy.; Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas, Austin, TX, USA.; Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.; Department of Nephrology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Microbiology, Immunology, and Transplantation, Laboratory of Molecular Immunology, Rega Institute, Katholieke Universiteit Leuven, Belgium.; Division of Nephrology, University Hospitals Leuven, Leuven, Belgium.; 1st Department of Nephrology and Transplantology, Medical University of Bialystok, Bialystok, Poland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.